Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: ACTELION PHARMACEUTICALS US, INC.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-06-06 to 2023-09-30
Current total value of award: $21877.52
Description: UPTRAVI 200MG